Nalaganje...
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
Antibody-drug conjugates (ADCs) represent a new class of cancer therapeutics. Their design involves a tumor-specific antibody, a linker and a cytotoxic payload. They were designed to allow specific targeting of highly potent cytotoxic agents to tumor cells whilst sparing normal cells. Frequent toxic...
Shranjeno v:
| izdano v: | MAbs |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966843/ https://ncbi.nlm.nih.gov/pubmed/27045800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1156829 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|